David Einhorn pitches at Sohn Investment Conference 2026

Invest Insight
9 followers
AI Generated·May contain errors
Video Summary
AI GeneratedThe speaker identifies five U.S. companies undergoing strategic transitions where management repositioning toward durable, cash-generative growth has created a value gap. By shifting business mixes and improving operational discipline, these companies are positioned to unlock significant shareholder value as market perceptions align with their improved business quality.
I want to thank the Sohn Investment Conference for inviting me to speak.
The last three years I have presented three different European companies that none of you
have ever heard of. So this year I'm going to introduce five U.S. companies in transition
and you probably know all of them. While the market appears expensive in the U.S.,
we're finding interesting investments where management is repositioning businesses
towards more durable, more disciplined, and more cash generative growth. The value creation
question is whether the management can convert the strategic change into better visibility,
better margins, and eventually a better multiple. So here's our disclosures. I'd like to remind
everyone what I'm about to present is in our portfolio and we may change our mind at any time.
The cartoon says this is a real opportunity to do exactly as we've done them before.
The five companies are in different industries but pose similar investor questions. Can business mix
improvement or repositioning unlock value? The investment opportunity in each instance is the
gap between the current perception and the future business quality. By the time we're done,
I hope you agree with me. Acadia Healthcare is the leading pure play behavioral health hospital
and methadone clinic operator in the United States. It operates 277 facilities with over
12,500 beds across the country that focus on some of the most acute mental health conditions,
including suicidal and homicidal ideation. The cartoon says yes, I'm an institutional
investor. In fact, I'm calling for one. And aren't most of us just a couple true social
posts away from needing Acadia's help? Acadia's stock peaked at almost $90 in 2022 and came under
pressure in 2024 following a New York Times investigation that alleged the company was
holding patients involuntarily beyond medical need. In addition, it has faced sexual assault
claims and lost a landmark jury trial in 2023 that changed the perceived litigation settlement costs.
Likely driven by the New York Times investigation, the DOJ is currently undergoing an exhaustive
review of Acadia's operating operations to ensure that it isn't doing anything funny.
Our research has shown that Acadia's average length of stay is in line with the industry and
that medical experts in the field view the company as reputable, responsible operator,
and that the problems are not pervasive. In addition to the external pressures, Acadia also
went on an overly aggressive expansion plan since 2021. In the last five years, it has spent around
$2 billion building out significant new capacity across the facility basis. The expansion was
mired by operational missteps, including significant cost overruns and licensing delays.
As a result, operating expenses ramped significantly while many of the newer facilities
remain underutilized. While seasoned facilities operate at the 70 to 80 percent occupancy
percentage, the newer facilities are currently operating in the 20 to 50 percent range.
The result of all these pressures can be seen in the five-year chart.
At the current price of around $25, the business trades at an EV to EVTA multiple of just 8.3,
compared to a historical low double-digit multiple, as the behavioral health market
has long-term secular growth and structural undercapacity. The stock is cheap but has,
in fact, found a catalyst. In January, Acadia's board was finally fed up with the CEO and fired
him. It hired Debbie Osteen, the previous CEO from 2018 to 2022, who tripled the stock price
during her initial tenure. The expansion CapEx has already been mostly spent. Now it needs to
earn a return by ramping occupancy. Acadia needs to bring these recent openings to the target
occupancy rates back to 70 or 80 percent and negotiate better reimbursement rates with managed
payers. Universal Health Services Behavioral Health Division, Acadia's largest public competitor,
grew reimbursement rates at double Acadia's pace in 2025.
The behavioral industry is still in structural undersupply, which is a tailwind for the company.
EBITDA last year was $609 million, but if Acadia can improve occupancy,
its target rates and additional capacity built and already paid for over the last five years
could generate an incremental $200 million in EBITDA. If we apply a recovery 10 times
multiple to that, we get to a share price of around $56, which is over double the current
share price. Next up, we have Centene Corporation, ticker CNC. The company had its worst year in 2025,
but we think the giant survives and come out stronger on the other side. The cartoon says,
ha ha, trust me, you'll blow through that $7,500 deductible in no time.
Centene is by far the largest of our companies today in today's presentation with a market cap
of $27 billion. Centene is the leading ACA exchange and Medicaid insurer. It provides
coverage to about 28 million people nationwide or about one in 15 people. It is dramatically
under-earning across all major business lines with a straightforward path to margin normalization over
the next two to three years. Adjusted pre-tax margins were 3.1 to 3.7 percent each year between
2016 and 2024. Last year, they collapsed to less than a percent, and this year they're guiding to
just over a percent. For the Medicaid segment, we can see the evolution of premiums paid per member
per month and the medical costs per member on the left side. The medical margin is on the right
side, which is before overhead. That's the difference between the two. In 2021, it was an
unusually good year as people avoided the doctor during COVID for anything other than emergencies.
But then the pent-up care and the drug cost inflation started in 2022 and margins compressed
from 12 percent all the way down to 5 percent by the second quarter of 2025. States are required
to pay Medicaid rates that produce actuarial sound margins over time. When the COVID distortion
passed, the recent data shows unacceptably low margins, which enables Centene to request price
increases. It will take another year to reflect full current costs and rates, and the 2027
implementation of the One Big Beautiful Bill Act policy will mute the recovery somewhat,
but the margin lift should occur by 2028. The cartoon says, see, I told you the free market
would adapt. The commercial segment is a short-cycle insurance business. Centene reprices
its entire ACA marketplace book over the course of a year. Centene cannot be forced to operate
in geographies or lines of businesses that don't produce acceptable margins. It is already
announced that the average price of its various ACA programs will increase about 35 percent this
year. Due to the mixed shift towards lower-tier plans, the actual increase in the average premium
per member will be lower than the mid-30s, but still up significantly from the prior year,
as management targets margin expansion of 400 basis points. The cartoon says, I don't think
management have to worry. AI can never replace us. Centene spends a significant cost and effort
processing a very large number of claims, and artificial intelligence is well-suited to automate
manually repetitive functions. We think Centene could be a huge beneficiary of AI in this fashion.
In 2025, Centene suffered from a mismatch between rapidly evolving medical cost trends and slower
annual price adjustments. Both segments will get repriced, and margins should normalize within a
few years. The ACA marketplace enrollment should decrease significantly in 2026, as enhanced ACA
subsidies expired at the end of 2025. This is factored into our normalized earnings number of
$8.49 a share. Applying a conservative PE of 10 to 12 times, we get to an $85 to $102 share price
compared to $56 today. It's worth noting that the targets management issued in 2024
imply greater than $11 of EPS on the current revenue base, so there could be even more upside.
Our next idea is Fluor Corporation, ticker FLR. The company is a survivor in every sense of the
word. It has transformed itself after a near-death experience, and is poised to success and
revaluation. The cartoon says, it's a big project, so proceed carefully, one step at a time, but
considering the deadline, make them really big, careful steps. Fluor Corporation is an engineering
procurement and construction or VPC manager. It oversees some of the world's most complex
large-scale projects, from initial design and engineering, through materials procurement,
to on-the-ground construction management. There's a lingering overhead and overhang from prior
mismanagement, including the near bankruptcy in 2020, and several negative margin fixed price
legacy projects nearing completion. The cartoon says, when life serves you lemonades, make lemonade,
then calculate your fixed and variable costs and add a reasonable markup in order to create a profit.
Even the cartoon got it right, but historically, EPC managers competed using fixed price models for
large multi-billion dollar projects. They basically took the risk of cost overruns.
In 2020, Fluor nearly went bankrupt after taking on several large lump-sum EPC projects, where it
bore most of the cost in the schedule risk, and this was right before inflation took off. The
company badly underestimated final costs and experienced major overruns, that nightmare legacy
projects are nearing completion, finally. In response, Fluor has emphasized cost plus work, which is now
over 80% of the current backlog. The cartoon says, scenic view, soon to be the site of an AI data
center. Investors remain focused on the past and under-appreciate Fluor's exposure to multiple
end markets that are each positioned for potential super cycles, including data centers, pharma
manufacturing, gas power generation, LNG infrastructure, nuclear power, and copper mining.
We are having a capex boom in this country, and Fluor is likely to get its share.
The company has a market cap of just 6.1 billion dollars and a fortress balance sheet,
giving it an enterprise value of 4.1 billion dollars. It recently monetized a strategic
investment and is using the proceeds to fund a 1.4 billion dollar share repurchase program,
which will account for about 20% of the shares. Construction-heavy EPC peers trade at a median
of 11 times EBIT, while engineering-heavy EPC peers trade at an even higher 21 times EBIT.
Fluor is involved across the board. Importantly, specialty players focused on artificial
intelligence end markets get an even higher premium multiples, often well above 20 times,
irrespective of their mix between engineering and procurement versus construction. As we believe
Fluor is close to showing the street that it too has significant exposure to this super cycle taking
place, Fluor has a large and healthy pipeline today is actively being paid to do front-end
work on projects representing roughly 60 billion dollars of future business. For context, that
compares to the current backlog of 26 billion and an annual revenue base of roughly 16 billion.
Management projects EBITDA going from 543 million to 900 million in 2029 as the cycle develops.
Fluor has good exposure to energy, so when the last cycle took off,
EBITDA tripled before peaking in 2014. If Fluor shows new client wins and a path towards drastically
increased EBITDA, the stock will do very well and perhaps even much better than we show here.
We assume here that the buyback gets completed using a blend and use a blended 14 times EBIT
multiple to get to $115 share price in a few years. We have two ideas left. One is sexy and
the other is not sexy. Both start with the ticker VS. We'll start with the sexy company.
Versant Media Group ticker VSNT. This company is just begging for some love. I'd like to call
out one of the long-standing sponsors of this conference CNBC for being a key part of this story
and I think I'm giving an interview afterwards so this is my opportunity to suck up so I get easy
questions. And Versant is super cheap and we find that extremely sexy. Versant is the larger is the
NBC Universal cable TV business that was spun out of Comcast in January. About 60% of Versant's
content is live news and sports and the rest is entertainment. The main channels are CNBC,
MSNOW and the Golf Channel and they're all top five in their respective genres.
Versant also holds non-cable assets like GolfNOW, Fundango and Rotten Tomatoes.
Everybody seems to hate this which created the opportunity to buy something that has been
foresold by non-economic actors and it is very cheap. The cartoon says, I'm sorry Mr. Bond but
you can't just leave Comcast. At the time of the spinoff, Versant's market cap was about 5%
of Comcast's market cap and the stock was dumped by those who received it. Index funds tracking
the S&P 500 and the Nasdaq 100 which include Comcast added to the technical selling pressure.
It took Versant a few months to find its footing. It's now trading around $41.
The headline numbers for last year look great. They sports a 19% free cash flow yield.
On 2026 consensus numbers, Versant is trading at 4.6 times PE and 4.2 times EBITDA.
So what's the problem? Well, Versant is somewhat of a melting ice cube. The market these days
think that melting ice cubes are nearly worthless. Actually, they turn into a fair amount of fresh
water. 2025 revenue declined 5%. EBITDA declined 9% and free cash flow declined about 9%.
Versant is facing well-understood structural headwinds from cord cutting but because it
focuses on news and live sports, it's somewhat insulated from the competition
from streaming platforms. Its main franchises are dominant in their respective fields and are
included in cable skinny bundles. Management goal is to pivot growth to non-pay TV which is
currently 19% of revenues and growing at mid-single digits while managing to slow the decline of the
cable TV assets. It has a goal within the next three to five years to double the revenue from
its digital platforms to a third and long-term the goal is having a 50-50 revenue split.
We model the next four years conservatively including a slow decline of the cable business
and the increase in other businesses. There's significant free cash flow for either share
repurchases or to grow the business through bolt-on acquisitions away from the cable TV business.
Using the simple model, Versant should generate over 60% of its market cap in free cash flow over
the next four years and you're still left with a good operating business that will only have
one turn of net leverage at a billion three of EBITDA. Our last investment is not sexy. The company
started with VS. You'll all know Victoria's Secret ticker VSCO. The company has been beaten up but
it's coming back harder and smarter. It is the ultimate fighter. The cartoon says chief I've got
a lead on Victoria's Secret. The brand has taken many hits including cultural backlash and a botched
acquisition of Adore Me and tariff headwinds. Victoria's Secret is one of the most iconic
brands in the world. For a few years they had a management team that in the DEI world decided to
broaden the brand appeal. They provided pivoted to a woke campaign of empowerment that the consumer
found inauthentic and got rid of the famous and they got rid of the famous fashion show.
New management came in has begun to reverse course including reinstating the fashion show
leading back into the company's more sexy DNA. Victoria's Secret's revenues were very stable
during the second half of last decade. Obviously it suffered during COVID as folks could not go
out and shop and had no need for fancy lingerie. In 2021 shows a big spike from people returning
and going out and women realizing that their lingerie had gotten too old. So then the brand
muddled for several years and the new CEO took over in September of 2024. She refreshed the
management team in the spring of 25. Both the Victoria's Secrets and Pink brands had begun
share gains despite pulling back on promotions. Operating margin had been falling for a long time
despite the stable revenues a classic sign of mismanagement. As revenues went up drastically
in 2021 margins rebounded. The margins remain at a lower level than we'd like but part of that's
related to the hit from tariffs in the last year. We'll likely see a bigger margin inflection in
2027 and there should even be a tariff refund coming. But the business is now stable with
growing revenues we expect good things to come. Margins are still barely half of historical levels
and continued brand momentum can drive explosive earnings growth. We show here the two-year price
targets using two different scenarios. The company has stated that they can get to 10% margins but
we think it's reasonable and even conservative and that's our base case. If they hit that we
believe the stock and trade in the low 80s are about 74% higher than today's stock price. Our
bull case is a bit higher than management's estimates but realistic if things go well.
It requires a 1% revenue beat this year and just under 5% revenue growth the next two years.
An 11% margin compared to management's guide of low double digits. The stock would more than double
if that happens. So that's the end of my five transition stories. I'll leave you with one final
cartoon that should resonate with other value investors. It says I don't want to change I want
Ollie you to change. Thanks again Devin, the Soan Conference, all the staff for making a special
event. It's always a highlight for me to be here and thank you for your attention.
